The result is the MGM Steel Challenge IPSC Series featuring three sizes of IPSC style target silhouette sets. Featuring the distinctive ring of the steel with each hit, that definite tone ...

Fate Therapeutics, Inc. (NASDAQ:FATE) announced today that it will present groundbreaking clinical data from its Phase 1 trial of FT819, an off-the-shelf, iPSC-derived CAR T-cell therapy, at the ...

The latest price target for Century Therapeutics (NASDAQ:IPSC) was reported by Chardan Capital on May 16, 2025. The analyst firm set a price target for $6.00 expecting IPSC to rise to within 12 ...

However, an impressive consensus price target is not the only factor that indicates a potential upside in IPSC. This view is strengthened by the agreement among analysts that the company will ...